S

SRTA

SRTA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
25%Bearish
Buy/Sell Ratio10% buys
BearishBullish
SRTA Live QuoteReal-time
$4.56
$0.15(-3.18%)1M
Day Range$4.54 – $4.84
Open$4.70
Previous Close$4.83
Volume1.13M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$431.42M
P/E Ratio (TTM)24.5
Forward P/E138.9
EPS (TTM)$-0.24
Price to Book1.6
Dividend Yield0.65%
Beta (Volatility)2.56
IndustryMEDICAL CARE FACILITIES
52-Week RangeCurrent: $4.56 (24%)
Low: $3.95High: $6.50
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$9.62-93.6% upside

Insider Buys

3

$108K

Insider Sales

9

$927K

Total Volume

$1.04M

12 transactions

Net Activity

$820K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
70CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Heavy distribution: sales represent 90% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
C
1

Cohen Amir

Chief Accounting Officer

0 buys3 sells

$410K total

H
2

Heyburn William A.

Co-CEO, CFO

1 buys1 sells

$262K total

T
3

Tomkiel Melissa M.

Co-CEO, GC

0 buys1 sells

$175K total

L
4

Love Reginald

Dir

0 buys3 sells

$125K total

W
5

Wunsch Scott M

CEO, Logistics

0 buys1 sells

$33K total

Trading History
SRTA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 5, 2026

2 weeks ago

Lauck Andrew

Dir

Director
Buy2.0K$5.00$10K

Aug 10, 2026

3 months ago

Love Reginald

Dir

Director
Sell5.1K$5.75$29K

Jun 8, 2026

5 months ago

Heyburn William A.

Co-CEO, CFO

CEO
Sell31.7K$5.87$186K

Jun 8, 2026

5 months ago

Cohen Amir

Chief Accounting Officer

C-Level
Sell4.7K$5.87$27K

Jun 8, 2026

5 months ago

Tomkiel Melissa M.

Co-CEO, GC

CEO
Sell29.7K$5.87$175K

Jun 8, 2026

5 months ago

Wunsch Scott M

CEO, Logistics

CEO
Sell5.5K$5.87$33K

May 21, 2026

6 months ago

Cohen Amir

Chief Accounting Officer

C-Level
Sell50.9K$5.89$299K

May 11, 2026

6 months ago

Cohen Amir

Chief Accounting Officer

C-Level
Sell14.3K$5.79$83K

Dec 9, 2025

11 months ago

Heyburn William A.

Co-CEO, CFO

CEO
Buy17.0K$4.47$76K

Dec 5, 2025

11 months ago

Lauck Andrew

Dir

Director
Buy5.0K$4.37$22K

Nov 20, 2025

12 months ago

Love Reginald

Dir

Director
Sell11.0K$4.37$48K

Nov 19, 2025

12 months ago

Love Reginald

Dir

Director
Sell11.0K$4.31$47K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
SRTA Buy Conviction10%
Industry Rank#541 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

SRTA has an insider buy conviction of 10%, compared to the Unknown sector buy average of 6%. SRTA ranks #541 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for SRTA

Over the last 90 days, corporate insiders at SRTA (SRTA) engaged in a total of 12 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 9 were sales. The total volume of insider trading reached $1.04M.

The net insider activity for SRTA shows a net selling bias of $820K. This activity represents a 10% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Cohen Amir (Chief Accounting Officer), who traded 50.9K shares valued at $299K on May 21, 2026.

Live Market News & Developments
Aggregated real-time headlines for SRTA (SRTA)
6 updates

Top Strata Critical Medical (SRTA) Competitors 2026

MarketBeatYesterday

Does Strata Critical Medical, Inc. (SRTA) Have the Potential to Rally 47.28% as Wall Street Analysts Expect?

Yahoo Finance88d ago

SRTA - Strata Critical Medical Inc Stock Price and Quote

Finviz178d ago

A $20 million authorization lets Strata buy back shares as it pursues acquisitions

Stock Titan17d ago

Strata Critical Medical, Inc. (SRTA) Upgraded to Buy: What Does It Mean for the Stock?

Yahoo Finance88d ago

Strata Critical Medical (SRTA) Stock Faces Clinical Progress And Lingering Losses

Simply Wall St108d ago

FAQs About SRTA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for SRTA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for SRTA is currently 70/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 3 purchases and 9 sales by company executives over the last 90 days.

The CEO Conviction Index for SRTA is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.